CDNA vs VCYT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

CDNA

29.8
AI Score
VS
VCYT Wins

VCYT

50.1
AI Score

Investment Advisor Scores

CDNA

30score
Recommendation
SELL

VCYT

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CDNA VCYT Winner
Revenue 249.65M 289.39M VCYT
Net Income 113.44M 54.20M CDNA
Net Margin 45.4% 18.7% CDNA
Operating Income 114.42M 45.63M CDNA
ROE 26.7% 3.9% CDNA
ROA 21.3% 3.6% CDNA
Total Assets 532.99M 1.49B VCYT
Cash 373.64M 299.52M CDNA
Current Ratio 4.58 9.16 VCYT
Free Cash Flow 29.26M 75.22M VCYT

Relative Price Performance (Last 90 Days)

CDNA 1M: +25.2% · 3M: +88.1% VCYT 1M: +6.6% · 3M: -20.1%

Current Technical Phase

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (21.1% over 20 days), RSI 68

RSI (14): 68.5 · Price: $70.74

VCYT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 55.7 · Price: $46.22

Fundamentals Snapshot

Metric CDNA VCYT
Market Cap — —
Forward P/E 54.8 23.8
Trailing P/E 33.3 32.0
Revenue (TTM) — —
Revenue Growth 0.5% 0.2%
Gross Margin 0.7% 0.7%
Operating Margin 0.0% 0.2%
EPS 2.08 1.40
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, VCYT is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.